Akihiro Homma Selected Research

Platinum

1/2021	Phase II trial of combination treatment with S-1/cetuximab in patients with platinum-ineligible recurrent and/or metastatic squamous cell carcinoma of the head and neck.
9/2020	Immunotherapy for squamous cell carcinoma of the head and neck.
8/2015	Comparison of acute toxicities associated with cetuximab-based bioradiotherapy and platinum-based chemoradiotherapy for head and neck squamous cell carcinomas: A single-institution retrospective study in Japan.
5/2013	Platinum-based chemotherapy plus cetuximab for the first-line treatment of Japanese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: results of a phase II trial.
10/2012	Platinum concentration in sentinel lymph nodes after preoperative intra-arterial cisplatin chemotherapy targeting primary tongue cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akihiro Homma Research Topics

Disease

41	Neoplasms (Cancer) 09/2022 - 09/2004
30	Squamous Cell Carcinoma of Head and Neck 07/2022 - 09/2004
24	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 01/2005
10	Carcinoma (Carcinomatosis) 04/2022 - 03/2005
9	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2018 - 03/2005
7	Neoplasm Metastasis (Metastasis) 02/2021 - 10/2012
6	Otitis Media 01/2022 - 01/2012
6	Lymphatic Metastasis 02/2021 - 08/2004
5	Maxillary Sinus Neoplasms 02/2022 - 10/2014
5	Vasculitis (Vasculitides) 01/2022 - 01/2012
5	Stomatitis 08/2019 - 01/2015
5	Tongue Neoplasms (Tongue Neoplasm) 04/2019 - 07/2011
5	Hypopharyngeal Neoplasms 04/2019 - 11/2010
4	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2022 - 01/2012
4	Rhinosinusitis 10/2021 - 10/2018
4	Laryngeal Neoplasms (Laryngeal Cancer) 10/2012 - 12/2008
3	Adenoid Cystic Carcinoma (Cylindroma) 04/2022 - 03/2005
3	Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma) 02/2022 - 03/2006
3	Dermatitis 11/2021 - 08/2015
3	Oropharyngeal Neoplasms 07/2017 - 01/2013
2	Inflammation (Inflammations) 01/2022 - 07/2017
2	Nasal Polyps (Nasal Polyp) 10/2021 - 10/2018
2	Infections 06/2021 - 07/2017
2	COVID-19 06/2021 - 01/2021
2	Asthma (Bronchial Asthma) 04/2021 - 01/2019
2	Deglutition Disorders (Dysphagia) 03/2021 - 01/2016
2	Vertigo (Positional Vertigo) 03/2021 - 01/2016
2	Disease Progression 01/2021 - 10/2020
2	Paralysis (Palsy) 08/2019 - 04/2019
2	Neutropenia 05/2019 - 11/2004
2	Body Weight (Weight, Body) 04/2019 - 01/2015
2	Sensorineural Hearing Loss 10/2018 - 01/2016
2	Mucositis 08/2015 - 01/2015
2	Cysts 12/2014 - 03/2006
2	Sinusitis 01/2012 - 03/2006
2	Wounds and Injuries (Trauma) 01/2010 - 12/2008
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2022
1	Sarcopenia 01/2022
1	Frailty 01/2022
1	Cachexia 01/2022
1	Facial Paralysis (Facial Palsy) 12/2021
1	Eosinophilia 10/2021
1	Cholesteatoma 10/2021
1	Aspiration Pneumonia 07/2021

Drug/Important Bio-Agent (IBA)

26	Cisplatin (Platino)FDA LinkGeneric 02/2022 - 09/2004
7	Biomarkers (Surrogate Marker)IBA 09/2022 - 02/2017
7	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 01/2012
7	Cetuximab (Erbitux)FDA Link 06/2021 - 05/2013
6	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2005
5	PlatinumIBA 01/2021 - 10/2012
5	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 09/2004
4	NivolumabIBA 01/2022 - 03/2021
4	Peroxidase (Myeloperoxidase)IBA 01/2022 - 01/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
3	SteroidsIBA 11/2021 - 01/2016
3	Cyclin D1IBA 02/2017 - 10/2007
3	Docetaxel (Taxotere)FDA Link 06/2015 - 10/2007
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2022 - 01/2018
2	ZincIBA 10/2021 - 04/2021
2	Serum AlbuminIBA 07/2021 - 01/2015
2	CytokinesIBA 01/2021 - 01/2005
2	Immune Checkpoint InhibitorsIBA 10/2020 - 09/2020
2	Pharmaceutical PreparationsIBA 08/2019 - 01/2018
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 04/2016
2	EnzymesIBA 10/2018 - 01/2016
2	IodineIBA 01/2018 - 01/2016
2	RhodaminesIBA 01/2018 - 01/2016
2	Fluorouracil (Carac)FDA LinkGeneric 06/2015 - 05/2013
2	CyclinsIBA 09/2013 - 10/2007
1	Protons (Proton)IBA 07/2022
1	AmidesIBA 07/2022
1	APTIBA 07/2022
1	Biological ProductsIBA 04/2022
1	Androgen Receptors (Androgen Receptor)IBA 04/2022
1	Tyrosine Kinase InhibitorsIBA 04/2022
1	Muscle Proteins (Muscle Protein)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Histones (Histone)IBA 01/2022
1	Messenger RNA (mRNA)IBA 10/2021
1	Chelating AgentsIBA 10/2021

Therapy/Procedure

37	Radiotherapy 04/2022 - 09/2004
34	Chemoradiotherapy 01/2022 - 09/2004
18	Neck Dissection (Radical Neck Dissection) 08/2022 - 08/2004
17	Therapeutics 04/2022 - 04/2015
14	Drug Therapy (Chemotherapy) 04/2022 - 11/2004
9	Intra-Arterial Infusions 01/2018 - 12/2006
4	Aftercare (After-Treatment) 07/2017 - 04/2009
3	Operative Surgical Procedures 12/2021 - 08/2014
3	Tracheostomy 06/2021 - 07/2017
3	Induction Chemotherapy 02/2021 - 06/2015
3	Laryngectomy 01/2010 - 12/2008
2	Combined Modality Therapy 02/2022 - 10/2012
2	Glossectomy 04/2019 - 12/2018
2	Brachytherapy 08/2008 - 12/2006
1	Secondary Prevention 01/2022
1	Length of Stay 01/2022
1	Drug Tapering 01/2022
1	Skin Care 11/2021
1	Total Parenteral Nutrition 07/2021
1	Gastrostomy 07/2021